FDA Drug Safety Warnings
― August 23, 2012 by Mark Abramowicz, M.D. The next issue of The Medical Letter will include an article on an FDA warning about the risk of QT prolongation and cardiac arrhythmias with the SSRI antidepressant citalopram (Celexa). The warning, which was based on case reports sent to the agency and on an unpublished study of [...] .





